EUCTR2008-005294-35-IT进行中（未招募）不适用
Multicenter Phase II study of Sequential Chemotherapy with Cisplatin/Gemcitabine Followed by Docetaxel in Elderly Advanced Non-Small-Cell Lung Cancer (NSCLC) patients - ELDERLY-NEXT
AZIENDA USL 6 LIVORNO ZONA LIVORNESE0 个研究点开始时间: 2009年1月22日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Histological or cytological diagnosis of non-small-cell lung cancer
- •-Measurable disease according to RECIST criteria (see appendix)
- •-Stage IIIB (ciyologicallly positive pleural effusion or metastatic supraclavicular lymphonodes)
- •-Age > 70 years
- •-ECOG performance status 0, 1.
- •-Life expectancy longer than 3 months
- •-Adequate bone marrow reserve (leukocyte count > 4.0 x 109/L, platelet count > 100 x 109/L)
- •-Adequate hepatic function (bilirubin level <1.5 mg/dL) and renal function (creatinine level < 1.5 mg/dL).
- •-Written informed consence
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Patient defined ?frail? according to the criteria reported in appendix
- •-Second primary malignancy
- •-Previuos chemotherapy for the metastatic disease
- •-Symptomatic brain metastases
- •-The presence of active infections
- •-Recent myocardial infarction
- •-Unstable angina
研究者
相似试验
进行中（未招募）
不适用
PHASE II MULTICENTRIC STUDY OF SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE FOLLOWED FROM DOCETAXEL IN ELDERLY PATIENTS WITH NOT SMALL CELLS LUNG CANCER NSCLC ADVANCED - POLTO-Elderly04EUCTR2005-001260-31-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE60
尚未招募
2 期
A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR/Dexamethasone in Patients with Unresectable Intrahepatic CholangiocarcinomaNL-OMON56819Memorial Sloan Kettering Cancer Center60
尚未招募
3 期
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical HysterectomyCTRI/2019/04/018382RG National Research Group Oncology
招募中
2 期
A randomized phase II study of systemic chemotherapy with and without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis (JCOG1301C:Trigger Study)HER2 positive gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis.JPRN-UMIN000016920Japan Clinical Oncology Group (JCOG)130
招募中
1 期
A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate polatuzumab vedotin and the bispecific antibody glofitamab in previously untreated aggressive B-cell lymphoma patients above 60 years of age ineligible for a fully dose R-CHOPaggressive large B-cell lymphomaMedDRA version: 20.0Level: HLTClassification code 10012819Term: Diffuse large B-cell lymphomasSystem Organ Class: 100000004851EUCTR2022-003398-51-ATInstitut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest125